Recruiting

Glaucoma Monitoring

Sponsor:

Synabridge Corporation

Code:

NCT00578110

Conditions

Glaucoma

Eligibility Criteria

Sex: All

Age: 40 - 70+

Healthy Volunteers: Accepted

Interventions

Glaucoma Diagnosis, Name: Neucodia

Study Details

Brief summary:

To introduce a rapid and objective electrophysiological technique that can assess visual function in the magnocellular pathway, which is thought to be affected in early-stage glaucoma.

Conditions

Glaucoma

Study ID

NCT00578110

Start date

Jan, 2008

Status verified date

Apr, 2010

Completion date

Apr, 2010

Anticipated

Primary completion date

Apr, 2010

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 40 - 70+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Age: 40 - 75 years old
  • Visual acuity: 20/30 or better

Exclusion Criteria:

  • Eye disease other than glaucoma

Study Design

Enrollment

180 participants

Anticipated

Allocation

Non randomized

Intervention Model

Parallel Assignment

Primary purpose

Diagnostic

Interventions and Outcome Measures

Arms

experimental: Group 1

Glaucoma Patients

experimental: Group 2

Glaucoma suspects

active comparator: Group 3

Controls

Interventions

Glaucoma Diagnosis, Name: Neucodia

Sensitivity and Specificity

Primary outcome measure

  • sensitivity and specificity [ Time Frame: one year ]

Central Contacts and Locations

Central contacts

Locations

School of Optometry, University of Alabama at Birmingham

Recruiting

Birmingham, Alabama, United States, 35294-0010

Contacts

Principal Investigator:

Eugenie Hartmann, Ph.D.

Yale Eye Center, Yale University

Recruiting

New Haven, Connecticut, United States, 06510

Contacts

Principal Investigator:

James C Tsai, M.D. MBA

Synabridge Corp.

Recruiting

Raritan, New Jersey, United States, 08869

Contacts

Principal Investigator:

George Hu, Ph.D.

Hamilton Eye Institute, The University of Tennessee

Recruiting

Memphis, Tennessee, United States, 38103-3452

Contacts

Principal Investigator:

Peter A Netland, MD, Ph.D.

More Information

Sponsor

Synabridge Corporation

Last update posted

Apr 2, 2010

Last verified

Apr, 2010

Keywords

  • glaucoma VEP detection device diagnosis vision

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Synabridge Corporation on 2010-04-02.